ROBO Global Healthcare Technology and Innovation ETF (HTEC) Stock Analysis
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
ROBO Global Healthcare Technology and Innovation ETF (HTEC) trades at $43.32. ROBO Global Healthcare Technology and Innovation ETF (HTEC) focuses on investing in companies benefiting from advancements in healthcare technology. Market cap: $67.4M, Sector: Financial services.
Price as of Aug 20, 2026 · Last analyzed: Mar 17, 2026Analyst Coverage for HTEC: HTEC does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates HTEC against Financial Services peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
Not enough scored data yet to form a council read on HTEC.
How is this calculated? →ROBO Global Healthcare Technology and Innovation ETF (HTEC) Financial Services Profile
ROBO Global Healthcare Technology and Innovation ETF (HTEC) provides targeted exposure to the healthcare technology sector, tracking an index of innovative companies. With a focus on growth through technological advancements and market adoption, HTEC offers investors a specialized investment vehicle within the broader asset management landscape, albeit with higher beta.
What Is the Investment Thesis for HTEC?
HTEC offers a focused investment in the high-growth healthcare technology sector. The fund's non-diversified approach allows for concentrated exposure to companies driving innovation in areas like medical devices, telehealth, and healthcare IT. With a beta of 1.58, HTEC exhibits higher volatility compared to the broader market, which could lead to outsized returns during periods of strong sector performance. The absence of a dividend yield reflects the fund's focus on capital appreciation rather than income generation. Key to HTEC's success is the continued adoption of healthcare technology solutions and the ability of its constituent companies to maintain a competitive edge through innovation. However, investors should be aware of the risks associated with a concentrated portfolio and the potential for market fluctuations to significantly impact performance.
Based on FMP financials and quantitative analysis
HTEC Key Highlights
HTEC's investment strategy focuses on companies with a portion of their business and revenue derived from the field of healthcare technology.
- The fund is non-diversified, concentrating its investments in a smaller number of companies within the healthcare technology sector.
- HTEC's beta of 1.58 indicates higher volatility compared to the broader market.
- The fund does not offer a dividend yield, focusing instead on capital appreciation.
- HTEC's market cap is $0.05B, reflecting its size within the ETF landscape.
Who Are HTEC's Competitors?
HTEC is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| BOAT SonicShares Global Shipping ETF | $48.73 | +1.95% | $57.0M | 50 |
| DEMZ Democratic Large Cap Core ETF | $47.61 | -0.09% | $68.1M | 47 |
| FDNI First Trust Dow Jones International Internet ETF | $28.66 | +1.58% | $31.5M | 44 |
| FMET FIDELITY METAVERSE ETF | $38.45 | -0.13% | $45.7M | 44 |
| HEAL Global X - HealthTech ETF | $29.93 | +3.33% | $32.8M | 44 |
| GESOX Lazard Global Equity Select Portfolio Open Shares | $19.13 | -0.10% | $79.9M | 52 |
| GESIX Lazard Global Equity Select Portfolio Institutional Shares | $19.17 | -0.14% | $79.9M | 52 |
| AGNG Global X - Aging Population ETF | $39.21 | +2.04% | $89.3M | 47 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are HTEC's Key Strengths?
Focused exposure to the high-growth healthcare technology sector.
- Potential for high returns due to the non-diversified investment approach.
- Transparent and rules-based index-tracking strategy.
- ROBO Global's brand recognition in the robotics and automation space.
What Are HTEC's Weaknesses?
Non-diversified investment approach increases risk.
- Higher beta indicates greater volatility compared to the broader market.
- Absence of dividend yield may not appeal to income-seeking investors.
- Small market cap may limit liquidity.
What Could Drive HTEC Stock Higher?
Increasing adoption of telehealth services due to the COVID-19 pandemic.
- Advancements in medical devices and healthcare IT.
- Growing adoption of artificial intelligence and personalized medicine in healthcare.
- Potential for new drug approvals and medical device innovations.
- Expansion of healthcare services in emerging markets.
What Are the Key Risks for HTEC?
Market fluctuations and economic downturns could negatively impact the fund's performance.
- Competition from other healthcare ETFs and investment funds could reduce investor demand.
- Regulatory changes and healthcare policy reforms could impact the healthcare technology sector.
- Technological obsolescence and disruption could render some healthcare technologies obsolete.
- The fund's non-diversified investment approach increases risk.
What Are the Growth Opportunities for HTEC?
- Expansion of Telehealth Services: The telehealth market is projected to reach $55.6 billion by 2027, driven by increasing demand for remote healthcare services and advancements in communication technologies. HTEC can benefit from this trend by investing in companies that provide telehealth platforms, remote patient monitoring devices, and virtual care solutions. The ongoing COVID-19 pandemic has accelerated the adoption of telehealth, creating a long-term growth opportunity for companies in this space.
- Advancements in Medical Devices: The medical device market is expected to reach $604 billion by 2028, fueled by technological advancements and an aging global population. HTEC can capitalize on this growth by investing in companies that develop innovative medical devices, such as robotic surgery systems, implantable devices, and diagnostic tools. These devices can improve patient outcomes, reduce healthcare costs, and drive revenue growth for the companies that develop them.
- Growth of Healthcare IT: The healthcare IT market is projected to reach $390 billion by 2027, driven by the increasing adoption of electronic health records, data analytics, and cloud-based solutions. HTEC can benefit from this trend by investing in companies that provide healthcare IT services, such as software development, data management, and cybersecurity. These services can help healthcare providers improve efficiency, reduce costs, and enhance patient care.
- Increasing Adoption of Artificial Intelligence in Healthcare: The AI in healthcare market is expected to reach $34 billion by 2027, driven by the increasing availability of healthcare data and advancements in AI algorithms. HTEC can capitalize on this growth by investing in companies that develop AI-powered solutions for healthcare, such as diagnostic tools, drug discovery platforms, and personalized medicine applications. These solutions can improve accuracy, speed up diagnosis, and personalize treatment plans.
- Expansion of Personalized Medicine: The personalized medicine market is projected to reach $3.2 trillion by 2028, driven by advancements in genomics, proteomics, and other omics technologies. HTEC can benefit from this trend by investing in companies that develop personalized medicine solutions, such as genetic testing services, targeted therapies, and companion diagnostics. These solutions can help healthcare providers tailor treatment plans to individual patients, improving outcomes and reducing side effects.
What Are HTEC's Competitive Advantages?
- Specialized Focus: HTEC's focus on healthcare technology provides a differentiated offering compared to broader healthcare ETFs.
- Index Tracking: The fund's index-tracking approach provides a transparent and rules-based investment strategy.
- Brand Recognition: ROBO Global's brand recognition in the robotics and automation space may attract investors to HTEC.
What Does HTEC Do?
ROBO Global Healthcare Technology and Innovation ETF (HTEC) is designed to provide investors with exposure to companies that are driving innovation and growth in the healthcare technology sector. The fund operates by investing at least 80% of its total assets in the securities included in its underlying index, or in depositary receipts representing those securities. This index is specifically constructed to measure the performance of companies that derive a significant portion of their business and revenue from healthcare technology. This includes companies involved in developing and marketing new technologies, products, and services within the healthcare industry. HTEC's investment strategy focuses on identifying companies with the potential for growth through innovation and the successful adoption of their technologies in the market. The ETF is non-diversified, meaning it concentrates its investments in a smaller number of companies within the healthcare technology sector. This concentration can lead to higher potential returns but also carries a higher degree of risk compared to more diversified investment vehicles. HTEC aims to capture the growth opportunities presented by the increasing integration of technology into healthcare, including areas such as medical devices, telehealth, diagnostics, and healthcare IT. By focusing on companies at the forefront of healthcare innovation, HTEC seeks to provide investors with a targeted and specialized investment option within the broader healthcare market.
What Products and Services Does HTEC Offer?
- Invests in companies with a portion of their business and revenue derived from healthcare technology.
- Tracks the performance of an index designed to measure healthcare technology companies.
- Focuses on companies with growth potential through innovation and market adoption.
- Allocates at least 80% of its total assets in securities of the index or depositary receipts.
- Provides exposure to companies involved in medical devices, telehealth, diagnostics, and healthcare IT.
- Offers a non-diversified investment approach, concentrating on a smaller number of companies.
How Does HTEC Make Money?
- HTEC generates revenue through management fees charged to investors.
- The fund's performance is directly tied to the performance of the healthcare technology companies it invests in.
- HTEC's business model relies on attracting and retaining investors seeking exposure to the healthcare technology sector.
What Industry Does HTEC Operate In?
HTEC operates within the asset management industry, specifically focusing on the healthcare technology sector. This sector is experiencing rapid growth driven by technological advancements, increasing demand for healthcare services, and the need for more efficient and cost-effective solutions. The competitive landscape includes other ETFs and investment funds that target the healthcare sector, such as BOAT (Virtus LifeSci Biotech Products ETF), DEMZ (DEMZ Political Contributions ETF), FDNI (Fidelity Disruptive Medicine ETF), FMET (FMET Emles Medical Breakthroughs ETF), and HEAL (AdvisorShares HealtheCare ETF). HTEC differentiates itself by focusing specifically on companies that are driving innovation and growth in healthcare technology.
Who Are HTEC's Key Customers?
- Institutional investors seeking exposure to the healthcare technology sector.
- Retail investors interested in thematic investing and healthcare innovation.
- Financial advisors looking for specialized investment vehicles for their clients.
ROBO Global Healthcare Technology and Innovation ETF (HTEC) Valuation Context
Valued at $67.4M, HTEC is classified as a micro-cap stock.
Key Financial Metrics
Return on equity for ROBO Global Healthcare Technology and Innovation ETF stands at 0.0%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 0.0%, showing how much profit it generates from its asset base. HTEC trades at a trailing price-to-earnings ratio of 0.00, below the Financial Services sector average of ~18x. Its free cash flow yield is 0.0%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.00 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is 0.0%, the inverse of the P/E and a quick read on earnings relative to price.
HTEC Financials
Bull Case vs Bear Case
Bull Case
- Focused exposure to the high-growth healthcare technology sector.
- Potential for high returns due to the non-diversified investment approach.
- Transparent and rules-based index-tracking strategy.
- ROBO Global's brand recognition in the robotics and automation space.
Bear Case
- Non-diversified investment approach increases risk.
- Higher beta indicates greater volatility compared to the broader market.
- Absence of dividend yield may not appeal to income-seeking investors.
- Small market cap may limit liquidity.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · August 2026
HTEC Latest News
No recent news available for HTEC.
HTEC Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for HTEC.
Price Targets
Wall Street price target analysis for HTEC.
HTEC MoonshotScore
What does this score mean?
The MoonshotScore rates HTEC 0-100 on quantitative fundamentals — growth, financial health, valuation, momentum, and risk.
Common Questions About HTEC (Financial Services)
What does ROBO Global Healthcare Technology and Innovation ETF do?
ROBO Global Healthcare Technology and Innovation ETF (HTEC) provides investors with targeted exposure to the healthcare technology sector. The fund tracks an index of companies that derive a portion of their business and revenue from healthcare technology, focusing on those with growth potential through innovation and market adoption.
What are the main risks for HTEC?
HTEC's main risks stem from its non-diversified investment approach and focus on the healthcare technology sector. Market fluctuations and economic downturns could negatively impact the fund's performance, as could competition from other healthcare ETFs. Regulatory changes and healthcare policy reforms could also affect the healthcare technology sector.
What are the key factors to evaluate for HTEC?
Evaluate HTEC on fundamentals, analyst consensus, and risk factors. HTEC offers a focused investment in the high-growth healthcare technology sector. Not financial advice.
How frequently does HTEC data refresh on this page?
HTEC's price was last updated on Aug 20, 2026 and refreshes on page view during U.S. market hours — it is not a real-time exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.
What has driven HTEC's recent stock price performance?
ROBO Global Healthcare Technology and Innovation ETF (HTEC) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Focused exposure to the high-growth healthcare technology sector. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider HTEC overvalued or undervalued right now?
ROBO Global Healthcare Technology and Innovation ETF (HTEC) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
How do I research HTEC before investing?
Before investing in ROBO Global Healthcare Technology and Innovation ETF (HTEC), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) analyst consensus ratings and price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Why might investors consider adding HTEC to a portfolio?
Key strength of ROBO Global Healthcare Technology and Innovation ETF (HTEC): Focused exposure to the high-growth healthcare technology sector. Weigh rewards against risks and diversify. Not financial advice.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- AI analysis pending for HTEC, limiting the depth of analysis.
- Financial data based on available information as of 2026-03-17.